SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001833141-24-000013
Filing Date
2024-08-08
Accepted
2024-08-08 13:42:58
Documents
9
Period of Report
2024-08-08

Document Format Files

Seq Description Document Type Size
1 6-K cybininc-form6xkq12025.htm 6-K 14396
2 EX-99.1 cybin-financialstatementsx.htm EX-99.1 447956
3 EX-99.2 cybin-mdaxq1x25xjune302024.htm EX-99.2 1129004
4 EX-99.3 q12024-ceocertificatecybin.htm EX-99.3 13163
5 EX-99.4 q12024-cfocertificatecybin.htm EX-99.4 12872
6 EX-99.5 cybnq12025-earningsprdraft.htm EX-99.5 31969
7 GRAPHIC image_0.jpg GRAPHIC 11299
8 GRAPHIC image_01.jpg GRAPHIC 11289
9 GRAPHIC image_0c.jpg GRAPHIC 14343
  Complete submission text file 0001833141-24-000013.txt   1701689
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 241187385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)